Table 1 Socio-demographic and clinical characteristics of the participants
Placebo (n = 32) | Topiramate (n = 30) | Total (n = 62) | |
|---|---|---|---|
Gender | |||
Female n (%) | 18 (56.2) | 14 (46.7) | 32 (51.6) |
Male n (%) | 14 (43.8) | 16 (53.3) | 30 (48.4) |
Age | |||
mean (sd) | 23.97 (8.16) | 23.7 (8.58) | 23.84 (8.3) |
median IQR] | 25 [15.75–29.25] | 24.5 [15.25–31.75] | 25 [15.25–1.75] |
Genetic subtype | |||
Deletion n (%) | 20 (62.5) | 22 (73.3) | 42 (67.7) |
Disomy n (%) | 11 (34.4) | 7 (23.3) | 18 (29) |
Defect of the imprinting centre n (%) | 1 (3.1) | 1 (3.3) | 2 (3.2) |
Body mass index (kg/m2) | |||
mean (sd) | 41.03 (12.9) | 40.43 (12.68) | 40.74 (12.69) |
median [IQR] | 40.2 [32.8–50.65] | 36.8 [31.92–49.3] | 39.35 [31.92–50.65] |
Setting | |||
Outpatient n (%) | 16 (50) | 17 (56.7) | 33 (53.2) |
Inpatient n (%) | 16 (50) | 13 (43.3) | 29 (46.8) |
